Loading
When cancer is advanced, doctors sometimes estimate how much time may be left so that people can plan care and what matters to them. Any estimate is about groups of people, is uncertain for one person, and you can choose whether and how you hear it.
ESMO's 2023 clinical practice guideline on prognostic evaluation in patients with advanced cancer in the last months of life (Stone and colleagues, ESMO Open) gives recommendations for patients with an expected survival of months or less. It notes that prognostication in practice often relies on subjective clinician predictions of survival, and reviews multivariable tools including the Palliative Prognostic Score (PaP), which stratifies patients into three groups by 30-day survival probability, its delirium-modified version, and the Palliative Prognostic Index, which combines performance status, oral intake, oedema, breathlessness and delirium. The guideline states that clinicians need to understand the characteristics and limitations of these tools for appropriate use.
Showing the technology this term belongs to: Early integrated palliative care.
Shares Advance care planning, Early integrated palliative care and the tag supportive.
Shares Advance care planning, Early integrated palliative care and the tag supportive.
Shares Advance care planning, Early integrated palliative care and the tag supportive.
Shares Early integrated palliative care and the tag supportive.
Shares Advance care planning and the tag supportive.
Shares Early integrated palliative care and the tag supportive.
Shares Advance care planning and the tag supportive.
Shares Early integrated palliative care and the tag supportive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/